Clinical Trial Update: Navitian PMCF Study ( rEPIC04C )

View source ↗

Summary

The Navitian PMCF Study (rEPIC04C), sponsored by Fundación EPIC, has completed its investigation in patients with coronary artery disease and ischemic heart dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemic Heart Disease

Drugs mentioned

• Navitian

Snippet

Sponsor: Fundación EPIC | Conditions: Coronary Artery Disease (CAD), Ischemic Heart Disease | Status: COMPLETED